کد مقاله کد نشریه سال انتشار مقاله انگلیسی نسخه تمام متن
3047004 1185051 2008 4 صفحه PDF دانلود رایگان
عنوان انگلیسی مقاله ISI
Drug-resistant epilepsy and epileptic phenotype-EEG association in MECP2 mutated Rett syndrome
موضوعات مرتبط
علوم زیستی و بیوفناوری علم عصب شناسی عصب شناسی
پیش نمایش صفحه اول مقاله
Drug-resistant epilepsy and epileptic phenotype-EEG association in MECP2 mutated Rett syndrome
چکیده انگلیسی

ObjectiveTo determine in MECP2-mutated Rett syndrome (RTT [MIM 312750]): (1) the prevalence of drug-resistant epilepsy (DRE); (2) whether the presence of DRE is related to the abnormal EEG patterns or to the particular MECP2 mutant genotype.MethodsRetrospective survey of a large population of patients (n = 154) evaluated between 1978 to 2007 (May) at the Child Psychiatry and Neurology Unit of Siena (Italy) with both clinical and genetic (i.e. MECP2 mutated) diagnoses of RTT. Some subjects were followed for up to 20 years. Among those, cases with epilepsy were first selected for study; within that group, cases with DRE were identified and studied. The association between clinical severity of their epilepsy and quantitative or qualitative scores of EEG severity was tested using rank coefficients (Spearman’s rho values). The relationship between DRE and RTT genotype category (i.e. gene deletion, gene duplication, early truncating mutation, late truncating mutation, and missense mutation) or a specific MECP2 genotype was tested using the chi-square test. A p-value <0.05 (two sided) was considered to indicate statistical significance.ResultsPrevalence of DRE was 16% (i.e. 16 DRE out of 100 MECP2-mutated RTT epileptic patients). No significant relationship was found between clinical severity of DRE and quantitative (p = 0.9190) or qualitative EEG scores (p = 0.1511). In addition, no significant relationship was found between the DRE and the RTT genotype category (chi-square = 1.147, DF = 4, p = 0.8867), or a specific MECP2 genotype (chi-square = 30.958, DF = 39, p = 0.8173).ConclusionsAlthough RTT MECP2-mutated patients suffer from a serious and progressive encephalopathy, it is “epileptogenic” but not “DREgenic” as they have a decreased risk (16%) for DRE compared to the general epileptic population (DRE: 20-40%). The presence of DRE is not related to abnormal EEG findings or a particular MECP2 mutant genotype.SignificanceThese observations could be of help in the practical management and family counseling.

ناشر
Database: Elsevier - ScienceDirect (ساینس دایرکت)
Journal: Clinical Neurophysiology - Volume 119, Issue 11, November 2008, Pages 2455–2458
نویسندگان
, , , , , , , , , ,